Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Dolby (DLB) Eyes Expansion In Europe, Clinches Dual Deals

Published 06/13/2018, 09:49 PM
Updated 07/09/2023, 06:31 AM

In the 2018 CineEurope trade show, Dolby Laboratories, Inc. (NYSE:DLB) announced its plans to expand operations into the European cinema market. In addition to this, the company also advertised its non-imitable imaging, audio, post-production and accessibility technology in the expo.

In sync with the aforementioned plan, Dolby Laboratories has inked an agreement with Odeon Cinemas Group — an acquired business arm of AMC Entertainment Holdings, Inc. (NYSE:AMC) — in a bid to unveil the first Dolby Cinema in the U.K. Per the deal, seven Dolby Cinema sites will be rolled out in the country over the next few years. Notably, per the agreement, Odeon Cinemas Group will utilize Dolby servers, speakers and processors across all of its European entities.

On the same day, Dolby Laboratories announced that it has entered into an agreement with Kinopolis to deploy its foremost Dolby Cinema in Germany. The first site is projected to open up later this year in Mathäser Palast, Munich.

Deployment of Dolby Cinemas in the U.K. and Germany will completely enhance the cinema experience for viewers in these countries. These theatres will be equipped with state-of-the-art projection and sound technology, new Oscar’s bars, luxury recliner seats, along with innovative beverage and food counters.

Furthermore, Dolby Laboratories shared its plans to ink a deal with Les Cinémas Gaumont Pathé during the second half of this year, for expanding the Dolby Cinema portfolio in France.

Over the past year, shares of this Zacks Rank #3 (Hold) company have rallied 29.5%, outperforming 26.6% growth recorded by the industry.



We believe the above-mentioned expansion moves in Europe will drive Dolby Laboratories’ overseas revenues and profitability, going forward. Also, other prospective deals, like Jinyi Cinemas’ plan to open up 20 Dolby Cinema sites in China, and Shochiku Multiplex Theatres’ agreement to deploy Dolby Cinema in Japan will fortify the company’s international business footprint.

Stocks to Consider

Two better-ranked stocks in the Zacks Consumer Discretionary sector are listed below:

AMC Networks Inc. (NASDAQ:AMCX) carries a Zacks Rank #2 (Buy). The company pulled off an average positive earnings surprise of 28.43%, over the last four quarters. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

American Public Education, Inc. (NASDAQ:APEI) also carries a Zacks Rank of 2. The company recorded an average positive earnings surprise of 21.52%, over the trailing four quarters.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



American Public Education, Inc. (APEI): Free Stock Analysis Report

Dolby Laboratories (DLB): Free Stock Analysis Report

AMC Networks Inc. (AMCX): Free Stock Analysis Report

AMC Entertainment Holdings, Inc. (AMC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.